Cannabis’ Plummeting Price-Per-Pound and the Rise of Delta-8 THC December 12, 2022 Steven Schain Hemp Business Executive, News & Insights 0 Comments Although forming America’s sixth-largest crop yielding 48.8 million pounds of flower and $27 billion in legal sales annually, marijuana’s plunging price-per-pound and the availability of cheaper, unregulated hemp-derived tetrahydrocannabinol (THC) products is thwarting the cannabis industry. Whether cultivated indoors, outdoors… Read More→
Anti-Legalization Big Pharma Company Has Their Synthetic THC Drug Approved By FDA March 25, 2017 AggregatedNews Policy & Legal 1 Comment Insys Therapeutics, a pharmaceutical company that was one of the chief financial backers of the opposition to marijuana legalization in Arizona last year, received preliminary approval from the Drug Enforcement Administration this week for Syndros, a synthetic marijuana drug. Insys gave $500,000… Read More→